Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2-breast cancer: comparison to the morphological and pathological response

被引：0
|
作者：
Boughdad, Sarah [1 ]
Champion, Laurence [1 ]
Becette, Veronique [2 ]
Cherel, Pascal [2 ]
Mouret-Fourme, Emmanuelle [2 ]
Edeline, Veronique [1 ]
Lemonnier, Jerome [3 ]
Lerebours, Florence [2 ]
Alberini, Jean-Louis [1 ]
机构：
[1] Ctr Rene Huguenin, Inst Curie, Nucl Med, St Cloud, France
[2] Ctr Rene Huguenin, Inst Curie, St Cloud, France
[3] Unicancer, Paris, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1311
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
    Boughdad, Sarah
    Champion, Laurence
    Becette, Veronique
    Cherel, Pascal
    Fourme, Emmanuelle
    Lemonnier, Jerome
    Lerebours, Florence
    Alberini, Jean-Louis
    CANCER IMAGING, 2020, 20 (01)
  • [2] Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response
    Sarah Boughdad
    Laurence Champion
    Veronique Becette
    Pascal Cherel
    Emmanuelle Fourme
    Jerome Lemonnier
    Florence Lerebours
    Jean-Louis Alberini
    Cancer Imaging, 20
  • [3] MRI Patterns in the evaluation of pathological response after Neoadjuvant Endocrine therapy in ER+/HER2-Breast Cancer and Implications on Surgical Planning
    Nakad, B.
    Milevsky, D.
    Simovici, P.
    Brodsky, A.
    BREAST, 2023, 68 : S57 - S58
  • [4] Estetrol for treatment of advanced ER+/HER2-breast cancer
    Schmidt, Marcus
    Hoenig, Arnd
    Zimmerman, Yvette
    Verhoeven, Carole
    Almstedt, Katrin
    Battista, Marco
    Lenhard, Hans Georg
    Krijgh, Jan
    Bennink, Herjan Coelingh
    CANCER RESEARCH, 2020, 80 (04)
  • [5] TILs in ER+/HER2-breast cancer
    Criscitiello, C.
    Vingiani, A.
    Maisonneuve, P.
    Viale, G.
    Viale, G.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2019, 30 : 3 - 3
  • [6] The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2-Breast Cancer
    Oshi, Masanori
    Takahashi, Hideo
    Tokumaru, Yoshihisa
    Yan, Li
    Rashid, Omar M.
    Nagahashi, Masayuki
    Matsuyama, Ryusei
    Endo, Itaru
    Takabe, Kazuaki
    CELLS, 2020, 9 (07) : 1 - 19
  • [7] Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2-breast cancer
    Ragusi, Max A. A.
    Winter-Warnars, Gonneke A. O.
    Wesseling, Jelle
    Linn, Sabine C.
    Beets-Tan, Regina G.
    van der Velden, Bas H. M.
    Elias, Sjoerd G.
    Gilhuijs, Kenneth G. A.
    Loo, Claudette E.
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1123):
  • [8] Response of persistent metastatic ER+/Her2-breast cancer treated with fulvestrant plus enzalutamide
    Richer, Jennifer
    Spoelstra, Nicole
    Winchester, Alyse
    Wulfkuhlue, Julia
    Gallagher, Rosa
    Sams, Sharon
    Vidal, Gregory
    Kabos, Peter
    Diamond, Jennifer
    Shagisultanova, Elena
    Afghahi, Anosheh
    Mayordomo, Jose
    McSpadded, Tessa
    Crawford, Gloria
    Borges, Virginia
    Gao, Dexiang
    Petricoin, Emanuel
    Elias, Anthony
    CANCER RESEARCH, 2022, 82 (04)
  • [9] Targeting of endocrine therapy-induced estrogen-receptor/HER2-cross-talk in circulating tumor cells from metastatic ER+/HER2-breast cancer: Implications for treatment of ER+/HER2-breast cancer
    Thaler, S.
    Rosswag, S.
    Pantel, K.
    Sleeman, J. P.
    Schmidt, M.
    Cotarelo, C. L.
    CANCER RESEARCH, 2019, 79 (04)
  • [10] Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2-breast cancer
    Dodaran, Maryam Soleimani
    Borgoni, Simone
    Sofyali, Emre
    Verschure, Pernette J.
    Wiemann, Stefan
    Moerland, Perry D.
    van Kampen, Antoine H. C.
    BMC CANCER, 2020, 20 (01)
12345